Life insurers in Singapore disbursed over $15 billion in claims and policy maturities during the first nine months of 2026, according to industry figures released on Nov 12 by the Life Insurance Association (LIA) Singapore. Policy maturities comprised about 74 per cent of total distributions, returning $11.2 billion to policyholders.
Individual health insurance claims absorbed another $2.2 billion, while payouts under individual life policies for critical illness, death and total permanent disability reached $1.7 billion. New commercial underwriting expanded alongside disbursements, with total weighted new business premiums advancing 15 per cent year on year to $5.5 billion across the nine-month period, aided by $1.8 billion secured in the third quarter.
LIA Singapore president Wong Sze Keed linked the product trajectory to evolving buyer priorities, noting that consumer allocations increasingly reflect dual demands for savings accumulation and baseline life coverage.
Shift Toward Investment Products
Consumer capital moved heavily into market-facing instruments. New business weighted premiums from investment-linked policies rose 22.6 per cent year on year to $2.5 billion, giving these products a 46 per cent share of total industry sales. By the third quarter, that allocation climbed to 49.7 per cent, up from 44.9 per cent in the second quarter and 42.7 per cent in the first.
Participating policies absorbed $1.2 billion in weighted new premiums, up 5.7 per cent from the previous year. Yet their share of overall sales slipped to 23 per cent from 25 per cent in 2025 as buyers preferred unit-linked funds offering direct equity exposure over pooled insurer funds with non-guaranteed bonuses.
“For some, access to professionally managed funds and financial advice may be part of the appeal,” she said.
Escalating Healthcare Claims
Medical claims continued an upward trajectory that tests underwriter pricing models. Integrated Shield Plans and their associated riders accounted for $2.1 billion of the $2.2 billion paid out for medical coverage, with riders alone generating 24.1 per cent of claims. Other private medical policies covered the remaining $115.2 million.
Quarterly claim volumes accelerated through the year. Shield plan payouts rose 6.7 per cent between the second and third quarters, expanding from $695.1 million to $742 million. Critical illness disbursements reached $756 million across the nine months.
Balance Sheet Implications
The liquidity returning to consumers through $11.2 billion in maturities offers direct fuel for private wealth managers and retail investment platforms operating in the city-state. Rather than recycling maturity proceeds into standard endowment covers, households are directing fresh commitments into higher-yield instruments, forcing traditional carriers to redesign legacy balance-sheet products.
For retail healthcare operators and private hospital networks, the climb in claim totals signals steady patient utilization alongside rising treatment costs. With 3.4 million individuals holding private medical plans, private insurers remain the primary payers for discretionary medical procedures. Underwriters face tightening underwriting margins if rider claims outpace base premium growth.
Trajectory of Policy Disclosures
The product shift began years prior. Investment-linked policies accounted for 37 per cent of new premiums in 2024 before advancing to 43 per cent across the comparable nine months of 2025. Rising equity participation has drawn regulatory scrutiny around consumer fee drag and downside exposure.
The Life Insurance Association is now preparing updated product highlight sheets alongside the Monetary Authority of Singapore to tighten cost disclosures, while industry committees conduct technical reviews of critical illness definitions to adjust coverage against newer diagnostic standards.
